LANTERN PHARMA INC
LTRN·51654W101·US·Common Stock·Healthcare - Biotechnology-Activist
LTRN (LANTERN PHARMA INC) is held by 25 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($454,948), RENAISSANCE TECHNOLOGIES LLC ($158,920), GEODE CAPITAL MANAGEMENT, LLC ($152,984). Net institutional sentiment: Mixed.
25
Holders
Avg rating(5 Elite)
$1.2M
Total Value
48% (28)
Fund Consensus
10 buying - 11 selling
Who's Trading
ActivistBABIOS ADVISORS GP, LLC4.5%May 15, 2026
InsiderSTSchalop Lee TroyBuy $100KMay 12, 2026
ActivistBEBios Equity Partners, LP3.7%Apr 16, 2026
ActivistTAThomas A. Satterfield, Jr.5.1%Apr 3, 2026
ActivistBIBios Fund I, LP2.6%Feb 23, 2026
InsiderKWKreis Leslie W.Sell $44KJun 13, 2025
InsiderFGFletcher Aaron G.L.Sell $44KJun 13, 2025
InsiderFGFletcher Aaron G.L.Sell $38KJun 13, 2025
InsiderKWKreis Leslie W.Sell $38KJun 13, 2025
InsiderFGFletcher Aaron G.L.Sell $22KJun 13, 2025
13F: Insider & Congress:
Showing 1-20 of 28
1 / 2
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer